Fundraising Fox
/Companies
Sign in

Capio Biosciences

Madison, US · Founded 2015 · Delaware corporation

Find your way into Capio Biosciences

Sign up to see every warm intro you have to Capio Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Capio Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.

BiotechHealthtechMedical Devices

Founders & leadership

Capio Biosciences was founded in 2015 by Seungpyo Hong.

SHSeungpyo Hong
Seungpyo HongCofounder and President
AWAndrew Wang
Andrew WangCo-Founder and Acting CEOPhysician scientist and radiation oncologist at UT Southwestern Medical Center with research focused on applying chemical and biomedical engineering principles to disease treatment. Co-founder and director of Capio Biosciences, which develops the CapioCyte platform for circulating tumor cell analysis.

Board

SX
Susie XuBoard director
FT
Fenlai TanBoard director
DC
David ChenBoard director

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 1 round · 2016

▶$2.9MraisedDec 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Susie XuDirector
  • Andrew WangExecutive Officer, Director
  • Fenlai TanDirector
  • Seungpyo HongExecutive Officer, Director
  • David ChenDirector
Offering amount
$2.9M
Amount sold
$2.9M
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

CapyBioCapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.

Companies working in the same space as Capio Biosciences.

Frequently asked questions

What does Capio Biosciences do?
Capio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.
Who founded Capio Biosciences?
Capio Biosciences was founded by Seungpyo Hong in 2015.
How much funding has Capio Biosciences raised?
Capio Biosciences has disclosed $2.9M raised across 1 round.
Where is Capio Biosciences headquartered?
Capio Biosciences is headquartered in Madison, US.